Where are the children in national hepatitis C policies? A global review of national strategic plans and guidelines.

ABSTRACT:

Background & aims

It is estimated that 3.26 million children and adolescents worldwide have chronic HCV infection. To date, the global response has focused on the adult population, but direct-acting antiviral (DAA) regimens are now approved for children aged ≥3 years. This global review describes the current status of policies on HCV testing and treatment in children, adolescents, and pregnant women in WHO Member States.

Methods

We identified national strategic plans and/or clinical practice guidelines (CPGs) for HCV infection from a World Health Organization (WHO) database of national policies from Member States as of August 2019. A standardised proforma was used to abstract data on polices or recommendations on testing and treatment in children, adolescents and preg

SUBMITTER: Malik F 

PROVIDER: S-EPMC7898178 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature